RESEARCH-USE BIOSIMILAR ANTIBODY
Rozanolixizumab
Monoclonal antibody · IgG4
Rozanolixizumab is a research-use biosimilar reference antibody targeting FCGRT/FcRn.
TARGETFCGRT
YMonoclonal antibody
CATALOGSC-BS-192
CATALOG NUMBERSC-BS-192
MOLECULAR WEIGHTApprox. 145.242 kDa
PRODUCT FORMATMonoclonal antibody
PRODUCT OVERVIEW
A research-use configuration for comparative antibody studies
Rozanolixizumab is a research-use biosimilar reference antibody targeting FCGRT/FcRn.
Rozanolixizumab is a recombinant research-use antibody directed against FCGRT.